Skip to mainSkip to footer
[Background image] [CI] Blue sky and buildings

Exploring the benefits of Carmignac Investissement

Published on
July 2, 2024
Read time
2 minute(s) read

In this note, you will find…

The added value of Kristofer Barrett, the talented new Fund manager of Carmignac Investissement, the 35-year global equity flagship.
Why is now the right time to start investing in global equities with Carmignac Investissement for long-term gains?
How the Fund has strategically adjusted its positioning to capitalize on the thriving tech and healthcare sectors while mitigating risks associated with stretched valuations.

Why Carmignac Investissement?

Carmignac Investissement: +12% annualized performance over 5 years*

The ability to identify thriving companies that capitalize on promising market dynamics and trends by leveraging on its global mandate, have contributed to the success of our EUR 4bn flagship strategy. However, complacency is not an option. The objective has always been to continuously evolve and reinforce the Fund’s capacity to keep its mandate intact. With this in mind, Kristofer Barrett took over the strategy in April 2024.

*Source: Carmignac, 28/06/2024.

A talented Fund manager supported by a strong team

Source: Carmignac, 2024, Morningstar 2024; Swedbank Robur Globalfond (ISIN: SE0000542979, Morningstar Category: *EAA Fund Global Large-Cap Growth Equity. Kristofer Barrett was managing Swedbank Robur Global Fund from 31/03/2016 to 31/01/2024.

Carmignac Know-How: Kristofer has support from the team of equity experts specializing in various sectors and geographic regions, who have played a crucial role in the performance of Carmignac Investissement over the past years.

A singular approach

  • The aim is to look at everything with an holistic viewpoint. It's important to look at where the companies are in the value chain, their competitive edge and their technology and their business model. The Fund favours innovative companies, with strong ownership structure/management offering indispensable products.
  • Price matters: We own companies trading at a price below their intrinsic value while having the potential to grow over time. That is why we invest in them over the long term.
  • An ability to invest in small & mid-caps that operate in niche businesses and excel in what they do.
  • Unconstrained in term of sectors, regions or investment style. The objective is to make the most of the flexibility to excel across all market environments.

Participating in the global economy

Carmignac Investissement strategically capitalizes on its global reach, with a substantial allocation to emerging markets. Recently, the Fund has further enhanced its investment in undiscovered prospects in Asia, such as the artificial intelligence (AI) value chain in Taiwan and Korea, as well as the promising banking and consumer sectors in India.

Why Carmignac Investissement now?

The Long-Term Appeal of Equities: Start Small, Stay Involved, Seize Opportunities

On paper, there are always reasons not to enter the stock market (valuations, geopolitical risks, economic growth, etc.). However, investing in an equity fund remains a highly compelling long-term strategy. Yet, timing the market is a challenge. Therefore, starting small and gradually increasing exposure is the optimal approach to capture opportunities as they arise.

A context that continues to be conducive for equities

A soft landing of the US economy, ongoing inflation deceleration, and accommodative central banks should continue to fuel a favorable environment for equities. However, as the supportive economic scenario has been largely factored into the market, active management of the underlying performance drivers becomes essential.

Performance drivers have been renewed

  • Since the beginning of the year, the Fund posted a performance of +21% vs +15% for its reference indicator*.
  • Since taking over the strategy in April 2024, Kristofer has revamped the portfolio, selling 12 stocks and acquiring 31 new companies out of a total of 72 stocks.

*Source: Carmignac, 28/06/2024. Reference Indicator: MSCI ACWI (USD) (Reinvested net dividends). The portfolios of Carmignac funds may change without previous notice.

A more robust portfolio construction

When Kristofer took over the strategy, markets were already at a high level, prompting him to carefully reshuffle the portfolio that would thrive in these market conditions. In recent weeks, we have strategically reduced the Beta of our portfolio, increased the average market capitalization, and improved the financial metrics such as balance sheet and growth rate. This has resulted in a more robust portfolio that is better equipped to withstand more challenging market conditions.

What are the main performance drivers?

The health care sector is experiencing a significant breakthrough with the success of Obesity drugs. To capitalize on this momentum, we are diversifying across the value chain.
Cencora, a US drug distributor with an oligopoly position, is poised to benefit from the increasing demand for weight-loss drugs. Furthermore, investing in selected managed care organizations in the US (Centene/ UnitedHealth/ Elevance) provides direct exposure to the growing healthcare spend in the country.

Source: Carmignac, June 2024.
The use of trademarks and logos does not imply any affiliation or endorsement. Reference to certain securities or financial instruments is given by way of illustration to highlight certain securities that are or have been present in the portfolios of the Funds in the Carmignac range. It is not intended to promote direct investment in these instruments and does not constitute investment advice. The Management Company is not prohibited from trading in these instruments prior to the publication of this communication. The portfolios of the Carmignac Funds are subject to change at any time.

A sustainable demand

Booming demand for AI has led, once again, to several large technology companies reaching all-time high valuations. Demand remains robust, with a combined capex of around $200bn this year from Amazon, Meta, Google, and Microsoft. Additionally, nations like Saudi Arabia, Singapore, Germany, UK, and India are investing heavily to be at the forefront of AI's potential, supporting the AI hardware ecosystem.

Investment strategy

However, such optimism around booming demand has started to be reflected in prices. Therefore, we have rebalanced our exposure by diversifying across the value chain and targeting niche companies with high return potential. Our objective is to identify sustainable business models that can deliver consistent returns over time.

Investment examples

  • In the AI industry, while Nvidia receives a lot of attention, it's important not to overlook the crucial role played by TSMC. As one of the world's most indispensable companies, TSMC produces semiconductors for Nvidia, which are then sold to major players like Microsoft and OpenAI.
  • TSMC relies on a network of subcontractors to support its operations. For example, Applied Materials manufactures machines used in the production of AI processors.
  • Moving further along the AI value chain, companies like SK Hynix and Samsung Electronics dominate the global market for "high bandwidth memory" chips, which are essential components for training AI systems like OpenAI's ChatGPT.
  • Meanwhile, Broadcom is addressing a significant challenge in AI infrastructure development: the need to connect thousands of servers across multiple data centers to create a robust network capable of handling AI workloads. Additionally, establishing internal networks within each server is also crucial.

Source: Carmignac, June 2024.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The use of trademarks and logos does not imply any affiliation or endorsement.

Carmignac Investissement A EUR Acc

ISIN: FR0010148981
Recommended minimum investment horizon
5 years
Risk indicator*
4/7
SFDR - Fund Classification**
Article 8

*Risk Scale from the KID (Key Information Document). Risk 1 does not mean a risk-free investment. This indicator may change over time. **Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.

Main risks of the fund

Equity: The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.
Currency: Currency risk is linked to exposure to a currency other than the Fund’s valuation currency, either through direct investment or the use of forward financial instruments.
Discretionary Management: Anticipations of financial market changes made by the Management Company have a direct effect on the Fund's performance, which depends on the stocks selected.
The Fund presents a risk of loss of capital. Please refer to the Fund’s prospectus to view the exhaustive list of risks.

Fees

ISIN: FR0010148981
Entry costs
4,00% of the amount you pay in when entering this investment. This is the most you will be charged. Carmignac Gestion doesn't charge any entry fee. The person selling you the product will inform you of the actual charge.
Exit costs
We do not charge an exit fee for this product.
Management fees and other administrative or operating costs
1,80% of the value of your investment per year. This estimate is based on actual costs over the past year.
Performance fees
20,00% max. of the outperformance once performance since the start of the year exceeds that of the reference indicator and if no past underperformance still needs to be offset. The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years, or since the product creation if it is less than 5 years.
Transaction Cost
0,35% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the investments underlying the product. The actual amount varies depending on the quantity we buy and sell.

Performance

ISIN: FR0010148981
Carmignac Investissement+19,9+17,4+25,0+18,9−18,3+4,0+33,7+24,7−14,2+4,8
Reference Indicator+17,0+7,9+25,3+18,1−13,0+27,5+6,7+28,9−4,8+8,9
Carmignac Investissement+24,5%+9,8%+10,6%
Reference Indicator+20,1%+10,9%+12,2%

Source: Carmignac at Oct 30, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference Indicator: MSCI AC World NR index

Share

Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions. This document is intended for professional clients.

This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.

Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.

Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA.
The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.

The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com/en, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.

  • In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.com/en-gb, or upon request to the Management Company, or for the French Funds, at the offices of the acilities Agent, Carmignac UK Ltd, 2 Carlton House Terrace, London, SW1Y 5AF. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.

  • In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.com/en-ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.

  • In Belgium: This document is intended for professional clients. This content has not been validated by FSMA. The decision to invest in the promoted fund should take into account all its characteristics or objectives as described in its prospectus. This communication is published by Carmignac Gestion S.A., a portfolio management company approved by the Autorité des Marchés Financiers (AMF) in France, and its Luxembourg subsidiary Carmignac Gestion Luxembourg, S.A., an investment fund management company approved by the Commission de Surveillance du Secteur Financier (CSSF). “Carmignac” is a registered trademark. “Investing in your Interest” is a slogan associated with the Carmignac trademark. This document does not constitute advice on any investment or arbitrage of transferable securities or any other asset management or investment product or service. The information and opinions contained in this document do not take into account investors’ specific individual circumstances and must never be interpreted as legal, tax or investment advice. The information contained in this document may be partial and could be changed without notice. This document may not be reproduced in whole or in part without prior authorisation. The risks and fees are described in the KID (Key Information Document). The prospectus, KID, the net asset-values and the latest (semi-) annual management report may be obtained, free of charge, in French or in Dutch, from the management company (tel. +352 46 70 60 1) or by consulting its website or www.fundinfo.com. These materials may also be obtained from Caceis Belgium S.A., the financial service provider in Belgium, at the following address: avenue du port, 86c b320, B-1000 Brussels. The Fund (fonds commun de placement or FCP) is a common fund in contractual form conforming to the UCITS Directive under French law. Access to the Fund may be subject to restrictions regarding certain persons or countries. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA. In case of subscription to a fund subject to Article 19bis of the Belgian Income Tax Code (CIR92), the investor will have to pay, upon redemption of his or her shares, a withholding tax of 30% on the income (in the form of interest, or capital gains or losses) derived from the return on assets invested in debt claims. Distributions are subject to withholding tax of 30% without income distinction. In case of subscription in a French investment fund (fonds commun de placement or FCP), you must declare on tax form, each year, the share of the dividends (and interest, if applicable) received by the Fund. Any complaint may be referred to complaints@carmignac.com or CARMIGNAC GESTION - Compliance and Internal Controls - 24 place Vendôme Paris France or on the website www.ombudsfin.be.

The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights at section 5 entitled "summary of investor rights" on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden. Belgium (French) ; Belgium (Dutch)

For Carmignac Portfolio Long-Short European Equities: Carmignac Gestion Luxembourg SA in its capacity as the Management Company for Carmignac Portfolio, has delegated the investment management of this Sub-Fund to White Creek Capital LLP (Registered in England and Wales with number OCC447169) from 2nd May 2024. White Creek Capital LLP is authorised and regulated by the Financial Conduct Authority with FRN : 998349.

Carmignac Private Evergreen refers to the Private Evergreen sub-fund of the SICAV Carmignac S.A. SICAV – PART II UCI, registered with the Luxembourg RCS under number B285278.